Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 12 apr 2018 - 07:00
- Statutory name argenx SE
- Title argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112
|201804120000000006_argenx SE_12042018_EN.pdf .pdf|
Date last update: 20 September 2019